Safety evaluation of fospropofol for sedation during minor surgical procedures

Journal of Clinical Anesthesia

Volumn 22, Issue 4, 2010, Pages 260-267

  Gan, Tong J ^a   Berry, Bradley D ^b   Ekman, Evan F ^c   Muckerman II, Richard C ^d   Shore, Neal ^e   Hardi, Robert ^f  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b International Heart Institute Montana   (United States)

^c Southern Orthopaedic Sports Medicine   (United States)

^d St Louis Women's Healthcare Group   (United States)

^e Carolina Urologic Research Center   (United States)

^f Metropolitan Gastroenterology Group PC   (United States)

Author keywords

Fospropofol; Minor surgery; Moderate sedation; Patient safety

Indexed keywords

ATROPINE; EPHEDRINE; FENTANYL; FOSPROPOFOL;

ADULT; AGED; ALERTNESS; ANESTHESIA LEVEL; APNEA; ARTICLE; BRADYCARDIA; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP SEDATION; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG FATALITY; DRUG INDUCED HEADACHE; DRUG SAFETY; FEMALE; HEART ARREST; HEART ATRIUM SEPTUM DEFECT; HEPATIC ENCEPHALOPATHY; HUMAN; HYPOTENSION; HYPOXEMIA; KIDNEY DISEASE; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MINOR SURGERY; MULTICENTER STUDY; NAUSEA; PARESTHESIA; PHASE 3 CLINICAL TRIAL; PREMEDICATION; PRIORITY JOURNAL; PRURITUS; RESTLESS LEGS SYNDROME; SCORING SYSTEM; SEDATION; SIDE EFFECT; SUPPLEMENTATION; VOMITING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANESTHETICS, INTRAVENOUS; DRUG ADMINISTRATION SCHEDULE; FEMALE; FENTANYL; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MIDDLE AGED; PROPOFOL; SURGICAL PROCEDURES, MINOR; YOUNG ADULT;

EID: 77952814150     PISSN: 09528180     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinane.2009.08.007     Document Type: Article

References (17)

1. American Society of Anesthesiologists Task Force on Sedation and Analgesia by Non-Anesthesiologists. Practice guidelines for sedation and analgesia by non-anesthesiologists. Anesthesiology 96 (2002) 1004-1017
2. Cohen L.B., Wecsler J.S., Gaetano J.N., et al. Endoscopic sedation in the United States: results from a nationwide survey. Am J Gastroenterol 101 (2006) 967-974
3. Reves J.G., Fragen R.J., Vinik H.R., and Greenblatt D.J. Midazolam: pharmacology and uses. Anesthesiology 62 (1985) 310-324
4. Pratila M.G., Fischer M.E., Alagesan R., Alagesan R., Reinsel R.A., and Pratilas D. Propofol versus midazolam for monitored sedation: a comparison of intraoperative and recovery parameters. J Clin Anesth 5 (1993) 268-274
5. Sipe B.W., Rex D.K., Latinovich D., et al. Propofol versus midazolam/meperidine for outpatient colonoscopy: administration by nurses supervised by endoscopists. Gastrointest Endosc 55 (2002) 815-825
6. Vicari J.J. Sedation and analgesia. Gastrointest Endosc Clin N Am 12 (2002) 297-311
7. Floyd M.D., Gervasini G., Masica A.L., et al. Genotype-phenotype associations for common CYP3A4 and CYP3A5 variants in the basal and induced metabolism of midazolam in European- and African-American men and women. Pharmacogenetics 13 (2003) 595-606
8. Kronbach T., Mathys D., Umeno M., Gonzalez F.J., and Meyer U.A. Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4. Mol Pharmacol 36 (1989) 89-96
9. Gibiansky E., Struys M.M., Gibiansky L., et al. AQUAVAN injection, a water-soluble prodrug of propofol, as a bolus injection: a phase I dose-escalation comparison with DIPRIVAN (part 1): pharmacokinetics. Anesthesiology 103 (2005) 718-729
10. Rex D.K. Review article: moderate sedation for endoscopy: sedation regimens for non-anaesthesiologists. Aliment Pharmacol Ther 24 (2006) 163-171
11. Struys M.M., Vanluchene A.L., Gibiansky E., et al. AQUAVAN injection, a water-soluble prodrug of propofol, as a bolus injection: a phase I dose-escalation comparison with DIPRIVAN (part 2): pharmacodynamics and safety. Anesthesiology 103 (2005) 730-743
12. Shah A., Fechner J., Struys M., and Mistry B. Differential PK/PD of propofol after intravenous fospropofol and Diprivan® in healthy subjects [Abstract]. Anesthesiology 107 (2007) A46
13. Cohen L.B. Clinical trial: a dose-response study of fospropofol disodium for moderate sedation during colonoscopy. Aliment Pharmacol Ther 27 (2008) 597-608
14. Silvestri G.A., Vincent B.D., Wahidi M.M., Robinette E., Hansbrough J.R., and Downie G.H. A phase 3, randomized, double-blind study to assess the efficacy and safety of fospropofol disodium injection for moderate sedation in patients undergoing flexible bronchoscopy. Chest 135 (2009) 41-47
15. Levitzky B.E., and Vargo J.J. Fospropofol disodium injection for the sedation of patients undergoing colonoscopy. Ther Clin Risk Manag 4 (2008) 733-738
16. Cohen L.B., Rex D.K., Kline J., and Wang C. Patient and physician satisfaction with fospropofol disodium: results of a phase 3, randomized, double-blind trial evaluating fospropofol disodium for moderate sedation in patients undergoing colonoscopy. [Abstract]. Gastrointest Endosc 65 (2007) AB367
17. Rex D.K., Cohen L.B., Kline J.K., and Wang C. Fospropofol disodium is effective and safe for sedation in patients undergoing colonoscopy: results of a phase 3, randomized double-blind trial. [Abstract]. Gastrointest Endosc 65 (2007) A369